Loading organizations...
§ Venture Capital · George Town, Midland, Cayman Islands
RocSon Medtech Fund operates as a dedicated venture capital firm specializing in the medical technology sector. The fund strategically deploys capital into promising companies spanning seed, early, and later stages of development within the medtech landscape. Its investment strategy focuses on identifying and supporting innovations that advance healthcare solutions.
Established around 2018, RocSon Medtech Fund emerged to address the unique capital requirements of the evolving medtech industry. While specific founding details are not publicly detailed, the fund operates from George Town, Cayman Islands, indicating a strategic base for international investment activities. The firm's inception reflects a commitment to fostering growth in this specialized market.
RocSon Medtech Fund primarily serves innovative medtech companies seeking crucial financial backing for product development, clinical trials, and market entry. The fund’s overarching vision centers on accelerating the commercialization and broader adoption of breakthrough medical technologies, ultimately aiming to improve patient outcomes and reshape the future of healthcare.
RocSon Medtech Fund has 2 tracked investments across 2 companies. The latest tracked deal is $20.0M Series C in Rapid Medical in April 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 23, 2019 | Rapid Medical | $20.0M Series C | John Mccallum, Bruce Wang | Agate Medical Investments |
| Apr 16, 2018 | Promaxo | $2.2M Series A Extension | Microport | Almond Tree Capital Fund |